rivastigmine has been researched along with Central Nervous System Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pant, A; Vasundhara, M | 1 |
| Aksoz, BE; Aksoz, E | 1 |
| Herrmann, N; Lanctôt, KL; Thompson, S | 1 |
3 review(s) available for rivastigmine and Central Nervous System Diseases
| Article | Year |
|---|---|
Endophytic fungi: a potential source for drugs against central nervous system disorders.
Topics: Central Nervous System Diseases; Donepezil; Endophytes; Fungi; Humans; Plants, Medicinal; Rivastigmine | 2023 |
Vital Role of Monoamine Oxidases and Cholinesterases in Central Nervous System Drug Research: A Sharp Dissection of the Pathophysiology.
Topics: Central Nervous System Agents; Central Nervous System Diseases; Cholinesterases; Combined Modality Therapy; Donepezil; Drug Design; Enzyme Inhibitors; Galantamine; Humans; Monoamine Oxidase; Rivastigmine; Structure-Activity Relationship; Tacrine | 2020 |
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome | 2004 |